Stock DYNS DYNC SPL
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases DYNC SPL

Equities

DYNS

US2680101050

Delayed Nasdaq
Other stock markets
 20:08:21 10/05/2024 BST 		5-day change 1st Jan Change
0.3689 USD -0.30% Intraday chart for DYNC SPL +0.35% -95.09%
2022 Senti Biosciences Completes Business Combination, Will Begin Trading on Nasdaq Thursday MT
2022 Dynamics Special Purpose Corp.(NasdaqCM:DYNS) dropped from NASDAQ Composite Index CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
DYNC SPL : SENTI BIOSCIENCES, INC. INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
PU
DYNC SPL : Senti Bio Debuts as Publicly Traded Company Focused on Developing Next-Generation Cell and Gene Therapies Engineered with Gene Circuits - Form 8-K
PU
DYNAMICS SPECIAL PURPOSE CORP. : Other Events, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Senti Bio Debuts as Publicly Traded Company Focused on Developing Next-Generation Cell and Gene Therapies Engineered with Gene Circuits
AQ
DYNAMICS SPECIAL PURPOSE CORP. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)
AQ
Dynamics Special Purpose : Senti Bio Names Dr. Kanya Rajangam to Newly Created Position of Chief Medical and Development Officer - Form 8-K
PU
DYNAMICS SPECIAL PURPOSE CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business Combination Agreement with DYNS - - DYNS announces effectiveness of registration statement on Form S-4 - - Meeting of DYNS stockholders to approve proposed business combination scheduled for Tuesday, June 7, 2022 at 10:00 a.m. ET - Form 8-K
PU
DYNAMICS SPECIAL PURPOSE CORP. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
DYNAMICS SPECIAL PURPOSE CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
DYNAMICS SPECIAL PURPOSE CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
DYNAMICS SPECIAL PURPOSE CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
DYNAMICS SPECIAL PURPOSE CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
Dynamics Special Purpose : Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies - Form 8-K
PU
DYNAMICS SPECIAL PURPOSE CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies
AQ
DYNAMICS SPECIAL PURPOSE CORP. Financial Statements and Exhibits (form 8-K/A)
AQ
DYNAMICS SPECIAL PURPOSE CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)
AQ
DYNAMICS SPECIAL PURPOSE CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
DYNAMICS SPECIAL PURPOSE CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DYNS Stock
  4. News DYNC SPL
  5. Press Releases